Consolidated Resources will Better Serve HeartCheck™, GEMS™ WIN and New Product Sales.
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed it has received new regulatory certification from the Canadian Medical Devices Conformity Assessment System (CMDCAS) specifically for its Toronto facilities. Global Business/Product Development, Regulatory, Quality, Development, Service and Sales Systems will now be based out of the Company’s Toronto location.
Securing ISO audit and EC-Certification will permit more efficient and cost effective marketing and sales support for CardioComm Solutions’ flagship products, the HeartCheck™ ECG devices and GEMS™ WIN (Global ECG Management Solution for Windows 7). With operations, sales and product development in one location, the Company will also be positioned to respond optimally to growing GEMS™ WIN sales and installation requests and GEMS™ WIN custom software engineering projects.
With product engineering, testing and quality auditing occurring at the same location, the Company’s capacity for meeting expanding applications for use of the HeartCheck™ devices, GEMS™ Home and the announced plans for a wireless HeartCheck™ device for Smartphone connectivity will also be strengthened.
The Company also confirms it will now close its Victoria location, which will provide operational and maintenance cost savings. A review of the CardioComm Solutions’ 2014 financial statements show a progressive reduction in overhead expenses, which will be further reduced with all corporate activities amalgamated into one location.
CardioComm Solutions is registered under Health Canada’s Therapeutic Products Programme (TPP) according to ISO 13485:2003 and CMDCAS as well as MDD regulations, for the Manufacturing and Distribution of Health Management Software Systems and Distribution of Health Monitoring Devices. The mission of the TPP, and the purpose of the audit, is to ensure that drugs, medical devices, and other therapeutic products available in Canada are safe, effective and are of high quality.
CardioComm Solutions has for several years received such clearances through its Victoria, BC, location which audit: Management Reviews, Procedures; Corrective Action Loops, Production and Process Controls; Customer Related Processes; Implementation of Applicable Canadian Medical Devices Regulations – Part 1 Requirements; Implementation of Regulatory Requirements of the Directive 93/42/EEC; and Document Control Processes. The audit concluded that CardioComm Solutions’ Toronto location has fulfilled the requirements of all applicable ISO 13485:2003 standards as well as Canadian regulatory requirements.
More information about the Company and its products and services can be found at www.cardiocommsolutions.com.
